One of New England’s most recent adult-use cannabis markets, Connecticut, surpassed $274 million in total marijuana sales last year with its 31 dispensaries, and ended 2023 with the highest month of sales in December, the state announced Wednesday. After December medical sales hit $10.3 million and recreational cannabis sales topped …
Toronto-based PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) is expecting to get full approval from the U.S. Food and Drug Administration (FDA) in April for a ketamine-based treatment it’s developed to be used for a wide array of “pain, mental health, and neurological disorders,” the company announced Wednesday. PharmaTher had …
“A patient’s treatment options should not be limited by the government, but rather, they should be determined in confidence between a patient and their doctor.” The post Delaware: House Committee Advances Legislation Expanding Physicians’ Abilities to Authorize Medical Cannabis appeared first on NORML.
Cannabis equity analyst Pablo Zuanic of Zuanic & Associates has initiated coverage on Statehouse Holdings Inc. (OTC: STHZF) with a neutral rating and Gold Flora (OTC: GRAM) with an overweight rating. Gold Flora Zuanic concedes that California may not be a good argument for the future of a cannabis company …